Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) have earned an average recommendation of “Moderate Buy” from the nine brokerages that are presently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $70.22.
A number of equities analysts recently commented on ACHC shares. KeyCorp raised Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 target price on the stock in a report on Tuesday, January 7th. Barclays cut their price target on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research note on Friday, November 22nd. StockNews.com lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, January 6th. Royal Bank of Canada reiterated an “outperform” rating and issued a $64.00 price target on shares of Acadia Healthcare in a research note on Friday, January 10th. Finally, Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and increased their price target for the stock from $45.00 to $75.00 in a research note on Thursday, December 12th.
Get Our Latest Stock Report on ACHC
Acadia Healthcare Price Performance
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in ACHC. Lindbrook Capital LLC lifted its holdings in shares of Acadia Healthcare by 1,342.0% in the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock valued at $29,000 after acquiring an additional 671 shares during the last quarter. Blue Trust Inc. lifted its holdings in shares of Acadia Healthcare by 69.4% in the 4th quarter. Blue Trust Inc. now owns 842 shares of the company’s stock valued at $33,000 after acquiring an additional 345 shares during the last quarter. Nisa Investment Advisors LLC increased its holdings in Acadia Healthcare by 40.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock valued at $41,000 after buying an additional 301 shares during the period. GAMMA Investing LLC increased its holdings in Acadia Healthcare by 57.1% during the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after buying an additional 241 shares during the period. Finally, Signaturefd LLC increased its holdings in Acadia Healthcare by 460.6% during the fourth quarter. Signaturefd LLC now owns 1,222 shares of the company’s stock valued at $48,000 after buying an additional 1,004 shares during the period.
About Acadia Healthcare
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Stories
- Five stocks we like better than Acadia Healthcare
- What Are Dividend Champions? How to Invest in the Champions
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- What is a Low P/E Ratio and What Does it Tell Investors?
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- Using the MarketBeat Stock Split Calculator
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.